These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9375512)

  • 21. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.
    Callister SM; Schell RF; Case KL; Lovrich SD; Day SP
    J Infect Dis; 1993 Jan; 167(1):158-64. PubMed ID: 8418162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease.
    Simon MM; Schaible UE; Wallich R; Kramer MD
    Immunol Today; 1991 Jan; 12(1):11-6. PubMed ID: 2015043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross immunity among types of Borrelia burgdorferi.
    Wienecke R; Neubert U; Volkenandt M
    Lancet; 1993 Aug; 342(8868):435. PubMed ID: 8101930
    [No Abstract]   [Full Text] [Related]  

  • 24. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease.
    Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G
    J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.
    Krause A; Burmester GR; Rensing A; Schoerner C; Schaible UE; Simon MM; Herzer P; Kramer MD; Wallich R
    J Clin Invest; 1992 Sep; 90(3):1077-84. PubMed ID: 1522216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins of Borrelia burgdorferi.
    Jiang W; Luft BJ; Munoz P; Dattwyler RJ; Gorevic PD
    J Immunol; 1990 Jan; 144(1):284-9. PubMed ID: 2295795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-reactivity between Lyme and syphilis screening assays: Lyme disease does not cause false-positive syphilis screens.
    Patriquin G; LeBlanc J; Heinstein C; Roberts C; Lindsay R; Hatchette TF
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):184-6. PubMed ID: 26707064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody.
    Volkman DJ; Luft BJ; Gorevic PD; Schultz J; Padovano L
    J Immunol; 1991 May; 146(9):3177-82. PubMed ID: 2016542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease.
    Sears JE; Fikrig E; Nakagawa TY; Deponte K; Marcantonio N; Kantor FS; Flavell RA
    J Immunol; 1991 Sep; 147(6):1995-2000. PubMed ID: 1716290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope mapping of heat shock protein 60 (GroEL) from Porphyromonas gingivalis.
    Maeda H; Miyamoto M; Kokeguchi S; Kono T; Nishimura F; Takashiba S; Murayama Y
    FEMS Immunol Med Microbiol; 2000 Jul; 28(3):219-24. PubMed ID: 10865174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an enzyme-linked immunosorbent assay that uses the 41-kd flagellin as the antigen for detection of antibodies to Borrelia burgdorferi in cattle.
    Ji B; Thomas CB; Collins MT
    Am J Vet Res; 1994 Sep; 55(9):1213-9. PubMed ID: 7802386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic and structural characterization of the dominant 66- to 73-kDa antigens of Borrelia burgdorferi.
    Luft BJ; Gorevic PD; Jiang W; Munoz P; Dattwyler RJ
    J Immunol; 1991 Apr; 146(8):2776-82. PubMed ID: 2016526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
    Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
    Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence homology between spirochaete flagellin and human myelin basic protein.
    Weigelt W; Schneider T; Lange R
    Immunol Today; 1992 Jul; 13(7):279-80. PubMed ID: 1382434
    [No Abstract]   [Full Text] [Related]  

  • 35. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.
    Rousselle JC; Callister SM; Schell RF; Lovrich SD; Jobe DA; Marks JA; Wieneke CA
    J Infect Dis; 1998 Sep; 178(3):733-41. PubMed ID: 9728542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.
    Jacek E; Tang KS; Komorowski L; Ajamian M; Probst C; Stevenson B; Wormser GP; Marques AR; Alaedini A
    J Immunol; 2016 Feb; 196(3):1036-43. PubMed ID: 26718339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serodiagnosis of Lyme disease.
    Jones JM
    Ann Intern Med; 1991 Jun; 114(12):1064. PubMed ID: 1867682
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serological screening for Lyme disease in Israel].
    Kletter Y; Berger SA
    Harefuah; 1993 Nov; 125(9):261-3, 328. PubMed ID: 8253415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of Borrelia antigens as potential vaccine candidates against Lyme borreliosis.
    Poljak A; Comstedt P; Hanner M; Schüler W; Meinke A; Wizel B; Lundberg U
    Vaccine; 2012 Jun; 30(29):4398-406. PubMed ID: 22100635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.